FDA Inspection 1214444 — Daniel Leonard IV, DO
The FDA completed an inspection of Daniel Leonard IV, DO on August 4, 2023 in Hastings, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 4, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Hastings, NE (United States)
Additional Details
Clinical Investigator (CI)